captopril has been researched along with Hyperglycemia in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balochnejadmojarrad, T; Chamani, E; Ebadi, Z; Fadaei, R; Fallah, S; Kazemi Fard, T; Moradi, N | 1 |
Alanazi, WA; Alhamami, HN; Briski, KP; Fakhruddin, S; Jackson, KE | 1 |
Gibas-Dorna, M; Kozlik, J; Krauss, H; Kupsz, J; Mikrut, K; Pruszynska-Oszmałek, E | 1 |
Kato, H; Murakami, M; Murakami, T; Ninomiya, T; Osajima, K; Otani, L | 1 |
Adams, L; Baron, AD; Broyde, A; Fernandez, R; Liu, Q; Parkes, DG | 1 |
Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
Al-Mulhim, AS; Fouad, AA; Jresat, I; Morsy, MA | 1 |
Djordjevic, V; Jevtovic, T; Kocic, G; Kocic, R; Pavlovic, D; Vlahovic, P | 1 |
Damas, J; Garbacki, N; Lefèbvre, PJ | 1 |
Cai, H; Oak, JH | 1 |
Gao, L; Kern, TS; Xi, X; Zhang, JZ | 1 |
Beretta-Piccoli, C; Ferrier, CP; Gerber, A; Link, L; Nützi, D; Weidmann, P | 1 |
Bindlish, V; Jaber, LA; Melchior, WR | 1 |
Dasgupta, T; McGowder, D; Ragoobirsingh, D | 1 |
Houston, MC | 1 |
2 review(s) available for captopril and Hyperglycemia
Article | Year |
---|---|
Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Capillary Resistance; Captopril; Diabetic Nephropathies; Dipeptides; Enalapril; Humans; Hyperglycemia; Lisinopril | 1993 |
Adverse effects of antihypertensive drug therapy on glucose intolerance.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Captopril; Coronary Disease; Diabetes Complications; Diagnosis, Differential; Diuretics; Female; Humans; Hyperglycemia; Hypertension; Male; Middle Aged | 1986 |
13 other study(ies) available for captopril and Hyperglycemia
Article | Year |
---|---|
Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Urea Nitrogen; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuretics; Drug Combinations; Drug Repositioning; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; MicroRNAs; Rats; Rats, Wistar; Spironolactone; Streptozocin; Transforming Growth Factor beta; Treatment Outcome | 2019 |
Hyperglycaemia induced by chronic i.p. and oral glucose loading leads to hypertension through increased Na
Topics: Animals; Blood Pressure; Captopril; Glucose; Hyperglycemia; Hypertension; Kidney Tubules, Proximal; Male; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium | 2018 |
Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Captopril; Catalase; Enalapril; Glutathione Peroxidase; Hydrogen Peroxide; Hyperglycemia; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2016 |
Sardine peptide with angiotensin I-converting enzyme inhibitory activity improves glucose tolerance in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Fishes; Hyperglycemia; Hypertension; Kidney Diseases; Male; Organ Size; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Stroke | 2009 |
The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Captopril; Cardiotonic Agents; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Hyperglycemia; Hypertension, Renal; Hypoglycemic Agents; Insulin Resistance; Kidney Diseases; Male; Peptides; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Venoms | 2010 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Caspase 3; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fas Ligand Protein; Glutathione; Heme Oxygenase (Decyclizing); Hyperglycemia; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Kidney Diseases; Male; Malondialdehyde; Microtubule-Associated Proteins; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Survivin; Tumor Necrosis Factor-alpha | 2013 |
Antioxidants modulate adenosine metabolism in rat mesangial cells cultured under high glucose conditions.
Topics: Adenosine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Cell Culture Techniques; Disease Models, Animal; Fibroblasts; Free Radical Scavengers; Glomerular Mesangium; Glutathione; Hyperglycemia; Melatonin; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasodilator Agents | 2002 |
Does insulin release kinins in rats?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Female; Glucose; Hyperglycemia; Insulin; Isometric Contraction; Kinins; Rats; Rats, Wistar; Uterine Contraction | 2005 |
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Hyperglycemia; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Superoxides; Tetrazoles; Vasodilation | 2007 |
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Capillaries; Captopril; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Hyperglycemia; Leukostasis; Losartan; Male; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Vascular Cell Adhesion Molecule-1 | 2007 |
Studies on acute glucose-induced aldosterone suppression: role of renin-angiotensin system.
Topics: Adult; Aldosterone; Blood Glucose; Captopril; Glucose Tolerance Test; Humans; Hydrocortisone; Hyperglycemia; Insulin; Male; Potassium; Renin; Renin-Angiotensin System | 1984 |
The hyperglycemic effect of S-nitrosoglutathione in the dog.
Topics: Animals; Ascorbic Acid; Blood Glucose; Blood Pressure; Captopril; Dogs; Female; Glutathione; Heart Rate; Hemodynamics; Hyperglycemia; Insulin; Male; Nitric Oxide Donors; Nitroso Compounds; Postprandial Period; Radioimmunoassay; S-Nitrosoglutathione | 1999 |